TRABALZINI, LORENZA
 Distribuzione geografica
Continente #
NA - Nord America 343
EU - Europa 144
AS - Asia 71
SA - Sud America 1
Totale 559
Nazione #
US - Stati Uniti d'America 342
IT - Italia 44
CN - Cina 37
IE - Irlanda 35
SE - Svezia 22
SG - Singapore 12
UA - Ucraina 10
DE - Germania 8
FR - Francia 7
HK - Hong Kong 6
VN - Vietnam 6
GB - Regno Unito 5
KR - Corea 5
IN - India 4
PL - Polonia 4
FI - Finlandia 3
NL - Olanda 3
AT - Austria 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
HR - Croazia 1
JP - Giappone 1
Totale 559
Città #
Chandler 81
Dublin 35
Fairfield 33
Torino 25
Ashburn 20
Beijing 19
Woodbridge 13
Cambridge 11
Fremont 11
Medford 11
Seattle 11
Jacksonville 10
Ann Arbor 9
Wilmington 9
Houston 8
Nyköping 8
Singapore 8
Pisa 6
Princeton 5
Boston 4
Dearborn 4
Dong Ket 4
Hong Kong 4
Warsaw 4
Guangzhou 3
Kunming 3
Redwood City 3
San Mateo 3
Seoul 3
Villeurbanne 3
Chennai 2
Freiburg 2
Grafing 2
Los Angeles 2
Nanjing 2
New York 2
Norwalk 2
Rome 2
San Diego 2
Turin 2
Xian 2
Amsterdam 1
Bari 1
Central District 1
Düsseldorf 1
Edinburgh 1
Hefei 1
Kagoshima 1
Kwangju 1
London 1
Milan 1
New Delhi 1
Pune 1
Rochester 1
San Francisco 1
Shaan 1
Shanghai 1
Taizhou 1
Toronto 1
Valencia 1
Vienna 1
Zagreb 1
Zhengzhou 1
Totale 415
Nome #
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 124
The Ras Superfamily of Small GTPases: The Unlocked Secrets 85
KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses 71
Ras Signaling - Methods and Protocols 68
Altered redox homeostasis and signaling in Cerebral Cavernous Malformation disease: towards a complex but unifying pathogenic mechanism and therapeutic implications 65
NADPH oxidase regulates the expression of angiogenic growth factors in Cerebral Cavernous Malformation cellular models 58
From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease 53
Cerebral Cavernous Malformations (CCM) Methods and Protocols 43
Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration 16
Totale 583
Categoria #
all - tutte 2.019
article - articoli 0
book - libri 0
conference - conferenze 458
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 2 4 1 5 12 16 17 8 8 4
2020/202191 11 8 10 4 5 5 8 7 12 6 8 7
2021/2022113 8 3 6 3 11 5 5 9 1 6 30 26
2022/2023150 17 17 10 20 12 40 12 8 8 0 5 1
2023/202473 13 7 4 5 4 9 3 11 0 5 2 10
2024/20254 0 3 1 0 0 0 0 0 0 0 0 0
Totale 583